R. Sadoughifar, D. Kaliterna, A. Abdelmaksoud, B. Türsen
This study evaluated the efficiency of a novel minimally invasive outpatient laser procedure, Endolift®, which destroys sebaceous glands with the combination of LASEmaR® 1500 and LIGHTSCAN™ - a fractional, non-ablative laser treatment. Thirty patients with acne vulgaris moderate to severe of both sex were treated, ranging from 18 to 35 years old; 70% had moderate and severe acne, and 30% had moderate acne. Only one session was performed of 200 microns of laser fibre inserted under the skin without anaesthesia. Eufoton® LASEmaR® 1500 works at a wavelength of 1470 nm. Three patients reported acne eruptions between 7 to 10 days after the treatment, which resolved in a few days; 70% of patients reported improvements after 3 to 4 weeks, and over time it has been going on to improve; the number of acne was significantly reduced, and the inflammation was superficial. Thirty% of patients reported improvements after 45 days. The final result is seen after 9 months; until then, we can expect gradual improvement. For 65% of the patients, one session was enough, with recommended measures to keep acne under control; for the 35%, we used 2 to 3 treatments based on LIGHTSCAN™ to keep acne under control. Patients reported a reduction in skin pores and an improvement in skin quality. There was no downtime and any side effects. In this study, patients with moderate to severe acne undergo 1 to 3 treatments based on direct optical energy reporting reduction of acne and skin inflammation.
{"title":"Topical treatment of acne vulgaris: Endolift® direct optical energy combined with LIGHTSCAN™ fractional laser","authors":"R. Sadoughifar, D. Kaliterna, A. Abdelmaksoud, B. Türsen","doi":"10.56609/jac.v41i1.70","DOIUrl":"https://doi.org/10.56609/jac.v41i1.70","url":null,"abstract":"This study evaluated the efficiency of a novel minimally invasive outpatient laser procedure, Endolift®, which destroys sebaceous glands with the combination of LASEmaR® 1500 and LIGHTSCAN™ - a fractional, non-ablative laser treatment. Thirty patients with acne vulgaris moderate to severe of both sex were treated, ranging from 18 to 35 years old; 70% had moderate and severe acne, and 30% had moderate acne. Only one session was performed of 200 microns of laser fibre inserted under the skin without anaesthesia. Eufoton® LASEmaR® 1500 works at a wavelength of 1470 nm. Three patients reported acne eruptions between 7 to 10 days after the treatment, which resolved in a few days; 70% of patients reported improvements after 3 to 4 weeks, and over time it has been going on to improve; the number of acne was significantly reduced, and the inflammation was superficial. Thirty% of patients reported improvements after 45 days. The final result is seen after 9 months; until then, we can expect gradual improvement. For 65% of the patients, one session was enough, with recommended measures to keep acne under control; for the 35%, we used 2 to 3 treatments based on LIGHTSCAN™ to keep acne under control. Patients reported a reduction in skin pores and an improvement in skin quality. There was no downtime and any side effects. In this study, patients with moderate to severe acne undergo 1 to 3 treatments based on direct optical energy reporting reduction of acne and skin inflammation.","PeriodicalId":15008,"journal":{"name":"Journal of applied cosmetology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43245210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D. Kaliterna, R. S. R. Sadoughifar, D. K. D. Kaliterna, R.J. Llergo Valdez R.J. Llergo Valdez, M. K. M. Kamalska, A. A. A. Abdelmaksoud, B. T. B. Türsen, D. Kaliterna
This study was designed to evaluate the efficiency of Endolift®, a novel minimally invasive outpatient laser procedure, for the nonsurgical treatment of eyelid ptosis. Thirty patients aged 30 to 55, 15 women and 15 men, were enrolled on this study. All patients had skin ptosis of the upper eyelids and the eyebrow area and dropping of the lateral part of the eyebrow. Patients have undergone a single treatment under micro drops of local anaesthesia. Treatment was performed using the Endolift® procedure, consisting of the device Eufoton® LASEmaR® 1500. This device uses a 1470 nm wavelength laser lead by micro-optical fibres of different calibres directly inside the skin. Twenty-four reported optimal results, 4 very good and 2 moderate. The first results were visible after 5 to 14 days and improved over time, and the average downtime was between 2 and 3 days due to the swelling. No other side effects were observed. These data confirm that Endolift® is a safe and effective procedure for the nonsurgical treatment of eyelid ptosis representing a real alternative to surgery.
{"title":"Nonsurgical eyelid ptosis: topical treatment with Endolift® direct optical energy","authors":"D. Kaliterna, R. S. R. Sadoughifar, D. K. D. Kaliterna, R.J. Llergo Valdez R.J. Llergo Valdez, M. K. M. Kamalska, A. A. A. Abdelmaksoud, B. T. B. Türsen, D. Kaliterna","doi":"10.56609/jac.v41i1.67","DOIUrl":"https://doi.org/10.56609/jac.v41i1.67","url":null,"abstract":"This study was designed to evaluate the efficiency of Endolift®, a novel minimally invasive outpatient laser procedure, for the nonsurgical treatment of eyelid ptosis. Thirty patients aged 30 to 55, 15 women and 15 men, were enrolled on this study. All patients had skin ptosis of the upper eyelids and the eyebrow area and dropping of the lateral part of the eyebrow. Patients have undergone a single treatment under micro drops of local anaesthesia. Treatment was performed using the Endolift® procedure, consisting of the device Eufoton® LASEmaR® 1500. This device uses a 1470 nm wavelength laser lead by micro-optical fibres of different calibres directly inside the skin. Twenty-four reported optimal results, 4 very good and 2 moderate. The first results were visible after 5 to 14 days and improved over time, and the average downtime was between 2 and 3 days due to the swelling. No other side effects were observed. These data confirm that Endolift® is a safe and effective procedure for the nonsurgical treatment of eyelid ptosis representing a real alternative to surgery.","PeriodicalId":15008,"journal":{"name":"Journal of applied cosmetology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43050241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M.M. Medhat M.M. Medhat, D. K. D. Kaliterna, A. A. A. Abdelmaksoud, A. E. A. El-Gammal
Hidradenitis suppurativa, also known as acne inversa, is a chronic inflammatory skin disease which affects ~1% of the world population. Hidradenitis suppurativa significantly impacts patients’ quality of life due to its chronic nature and frequently occurring relapses. Therefore, Hidradenitis suppurativa patients need to get an early diagnosis. This study was designed to evaluate the efficiency of Endolift®, a novel minimally invasive outpatient laser procedure, for treating Hidradenitis suppurativa. Thirty patients in the range of 19 to 43 y-o, 20 women and 10 men, were enrolled on this study. Patients have undergone a single treatment under tumescent anaesthesia. Treatment was performed using the Endolift® procedure, consisting of the device Eufoton® LASEmaR® 1500. This device uses a 1470 nm wavelength laser lead by micro-optical fibres of different calibres directly inside the skin. This treatment aims to destroy problematic glands with a thermal effect and remove them with liposuction. The treatment has a strong anti-inflammatory effect and promotes neocollagenesis. Eighteen patients obtained optimal results, 5 had good results, and 7 reported moderate results. The treatment was repeated for 7 patients for small refractory areas. Patients with earlier onset of the disease generally had better results. No side effect was recorded. Endolift® treatment represents a big hope for the patient because it is a safe, effective, minimally invasive procedure and can be repeated.
{"title":"Hidradenitis suppurativa: interstitial laser treatment with Endolift® procedure using Eufoton® LASEmaR®1500 1470-nm wavelength","authors":"M.M. Medhat M.M. Medhat, D. K. D. Kaliterna, A. A. A. Abdelmaksoud, A. E. A. El-Gammal","doi":"10.56609/jac.v41i1.68","DOIUrl":"https://doi.org/10.56609/jac.v41i1.68","url":null,"abstract":"Hidradenitis suppurativa, also known as acne inversa, is a chronic inflammatory skin disease which affects ~1% of the world population. Hidradenitis suppurativa significantly impacts patients’ quality of life due to its chronic nature and frequently occurring relapses. Therefore, Hidradenitis suppurativa patients need to get an early diagnosis. This study was designed to evaluate the efficiency of Endolift®, a novel minimally invasive outpatient laser procedure, for treating Hidradenitis suppurativa. Thirty patients in the range of 19 to 43 y-o, 20 women and 10 men, were enrolled on this study. Patients have undergone a single treatment under tumescent anaesthesia. Treatment was performed using the Endolift® procedure, consisting of the device Eufoton® LASEmaR® 1500. This device uses a 1470 nm wavelength laser lead by micro-optical fibres of different calibres directly inside the skin. This treatment aims to destroy problematic glands with a thermal effect and remove them with liposuction. The treatment has a strong anti-inflammatory effect and promotes neocollagenesis. Eighteen patients obtained optimal results, 5 had good results, and 7 reported moderate results. The treatment was repeated for 7 patients for small refractory areas. Patients with earlier onset of the disease generally had better results. No side effect was recorded. Endolift® treatment represents a big hope for the patient because it is a safe, effective, minimally invasive procedure and can be repeated.","PeriodicalId":15008,"journal":{"name":"Journal of applied cosmetology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42640925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. Zanotti, U. Luciano, P. Faccioni, P. Montagna, A. Bertajola, M. Zarantonello, T. Zambotti, M. Magi, F. Melloni, A. Iurlaro, C. Alberti, D. De Santis, N. Zerman
Since its inception, modern dentistry has been a discipline in continuous evolution. Thanks to this progress, the prosthetic rehabilitation of the edentulous patient can now be effectively addressed by multiple therapeutic approaches rooted in the decision-making marriage between patient and clinician in both partial and total edentulous patients. From a historical perspective, the aesthetic-functional restoration of the completely edentulous maxillary arch has been subverted in the possibilities of intervention by the introduction of implantology, which has made it possible to overcome the otherwise mandatory use of removable devices with complete mucous support (1). The current study is intended to be an example of this evolution by describing one out of five clinical cases performed. Furthermore, it is intended to demonstrate how the newly proposed implant-prosthetic techniques, where a fixed implant rehabilitation is not possible due to age constraints, lack of bone support or unfavourable mechanical-aesthetics parameters, allow the rehabilitation of the upper total edentulous jaw with a removable device without a solidarizing intermediate bar to rely upon for the implants. The implants and the whole rehabilitation are, however, consolidated thanks to the stability provided by the presence of a telescopic connection, combining viable long-term survival (2) with optimal results for the patient in terms of cost (3), comfort, chewing capability (4), aesthetics and home hygiene.
{"title":"Minimally invasive rehabilitation with total removable implants supported prosthesis with conometric connection","authors":"G. Zanotti, U. Luciano, P. Faccioni, P. Montagna, A. Bertajola, M. Zarantonello, T. Zambotti, M. Magi, F. Melloni, A. Iurlaro, C. Alberti, D. De Santis, N. Zerman","doi":"10.56609/jac.v41i1.157","DOIUrl":"https://doi.org/10.56609/jac.v41i1.157","url":null,"abstract":"Since its inception, modern dentistry has been a discipline in continuous evolution. Thanks to this progress, the prosthetic rehabilitation of the edentulous patient can now be effectively addressed by multiple therapeutic approaches rooted in the decision-making marriage between patient and clinician in both partial and total edentulous patients. From a historical perspective, the aesthetic-functional restoration of the completely edentulous maxillary arch has been subverted in the possibilities of intervention by the introduction of implantology, which has made it possible to overcome the otherwise mandatory use of removable devices with complete mucous support (1). The current study is intended to be an example of this evolution by describing one out of five clinical cases performed. Furthermore, it is intended to demonstrate how the newly proposed implant-prosthetic techniques, where a fixed implant rehabilitation is not possible due to age constraints, lack of bone support or unfavourable mechanical-aesthetics parameters, allow the rehabilitation of the upper total edentulous jaw with a removable device without a solidarizing intermediate bar to rely upon for the implants. The implants and the whole rehabilitation are, however, consolidated thanks to the stability provided by the presence of a telescopic connection, combining viable long-term survival (2) with optimal results for the patient in terms of cost (3), comfort, chewing capability (4), aesthetics and home hygiene.","PeriodicalId":15008,"journal":{"name":"Journal of applied cosmetology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47182768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Markabaeva, D. Kaliterna, S. Karimov, A. Abdelmaksoud, M. Kamalska, I. Binic
This study was designed to evaluate the efficiency of Endolift®, a novel minimally invasive outpatient laser procedure, for the treatment of cutaneous ptosis. Thirty patients aged 25 to 60, 25 women and 5 men, were enrolled on this study. Twenty women got skin ptosis after pregnancy, while 5 women and 5 men got skin laxity after losing body weight. Patients have undergone a single treatment under local anaesthesia. Treatment was performed using the Endolift® procedure, which consists of the laser Eufoton® LASEmaR® 1500. This device uses a 1470 nm wavelength laser lead by micro-optical fibres of different calibres directly inside the skin. Optimal results were obtained in 70% of patients, 18% had good results, and 12% reported moderate results. No patients reported any hematoma. Ten patients took analgesics for a maximum of two days; 5 reported pain resolved after 7 days. In addition, 8 patients reported their first results after 7 to 20 days improving results over time. The follow-up was done after 1, 3, 6 and 12 months when all patients overcame the expected result. No side effect was recorded. These data confirm that Endolift® is a safe and effective procedure for cutaneous ptosis representing a new category for body treatments and a real alternative to surgery.
{"title":"Topical treatment of cutaneous ptosis: Endolift® treatment with 1470-nm wavelength Eufoton® LASEmaR®1500","authors":"A. Markabaeva, D. Kaliterna, S. Karimov, A. Abdelmaksoud, M. Kamalska, I. Binic","doi":"10.56609/jac.v41i1.69","DOIUrl":"https://doi.org/10.56609/jac.v41i1.69","url":null,"abstract":"This study was designed to evaluate the efficiency of Endolift®, a novel minimally invasive outpatient laser procedure, for the treatment of cutaneous ptosis. Thirty patients aged 25 to 60, 25 women and 5 men, were enrolled on this study. Twenty women got skin ptosis after pregnancy, while 5 women and 5 men got skin laxity after losing body weight. Patients have undergone a single treatment under local anaesthesia. Treatment was performed using the Endolift® procedure, which consists of the laser Eufoton® LASEmaR® 1500. This device uses a 1470 nm wavelength laser lead by micro-optical fibres of different calibres directly inside the skin. Optimal results were obtained in 70% of patients, 18% had good results, and 12% reported moderate results. No patients reported any hematoma. Ten patients took analgesics for a maximum of two days; 5 reported pain resolved after 7 days. In addition, 8 patients reported their first results after 7 to 20 days improving results over time. The follow-up was done after 1, 3, 6 and 12 months when all patients overcame the expected result. No side effect was recorded. These data confirm that Endolift® is a safe and effective procedure for cutaneous ptosis representing a new category for body treatments and a real alternative to surgery.","PeriodicalId":15008,"journal":{"name":"Journal of applied cosmetology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43629509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. M. G. G. Martínez Grau, C. G. M. C. Gómez Martín
Purpose: Blepharoplasty is a common surgical technique, performed mainly for aesthetic purposes and for functional disorders of the periorbital, which corrects excess skin of the upper eyelids or excess fat in the lower bags. As a side effect, periorbital hematomas usually occur, which can be annoying for patients. Ice water compresses and head elevation are used, without scientific evidence, for recovery, but specific creams, such as those with lactoferrin, can accelerate tissue repair processes. The study aimed to assess the efficacy of a cream containing lactoferrin encapsulated in liposomes, Kelador®, to reduce post-blepharoplasty bruises. Methods: This controlled, prospective, randomized, single-centre pilot clinical study was conducted at the Barraquer Clinic in Barcelona, Spain. All patients underwent a blepharoplasty, and periorbital hematomas were treated with a Chelating Cream (Kelador®). Patients were followed up two and nine days after surgery, where clinical data and photographs were taken. Images were assessed through an objective analysis method developed with the ImageJ® software. Results: Nineteen patients were enrolled, 16 women and three men. The median age was 60.37 years (SD 14.22), and the median of treatment days was 8.2 (SD 1.6). The mean Reduction % in the treated eyes was 33.3 (SD 31,0), and in untreated eyes, 17.7 (SD38,1). Differences were statistically significant (p = 0.00667). Conclusions: Using a Chelating Cream containing lactoferrin encapsulated in liposomes, such as Kelador®, accelerates the reduction of bruise colour after a periocular intervention such as blepharoplasty.
{"title":"Comparative study of the efficacy of a Chelating Cream in patients with bruises after blepharoplasty: a pilot study","authors":"G. M. G. G. Martínez Grau, C. G. M. C. Gómez Martín","doi":"10.56609/jac.v40i2.25","DOIUrl":"https://doi.org/10.56609/jac.v40i2.25","url":null,"abstract":"Purpose: Blepharoplasty is a common surgical technique, performed mainly for aesthetic purposes and for functional disorders of the periorbital, which corrects excess skin of the upper eyelids or excess fat in the lower bags. As a side effect, periorbital hematomas usually occur, which can be annoying for patients. Ice water compresses and head elevation are used, without scientific evidence, for recovery, but specific creams, such as those with lactoferrin, can accelerate tissue repair processes. The study aimed to assess the efficacy of a cream containing lactoferrin encapsulated in liposomes, Kelador®, to reduce post-blepharoplasty bruises. Methods: This controlled, prospective, randomized, single-centre pilot clinical study was conducted at the Barraquer Clinic in Barcelona, Spain. All patients underwent a blepharoplasty, and periorbital hematomas were treated with a Chelating Cream (Kelador®). Patients were followed up two and nine days after surgery, where clinical data and photographs were taken. Images were assessed through an objective analysis method developed with the ImageJ® software. Results: Nineteen patients were enrolled, 16 women and three men. The median age was 60.37 years (SD 14.22), and the median of treatment days was 8.2 (SD 1.6). The mean Reduction % in the treated eyes was 33.3 (SD 31,0), and in untreated eyes, 17.7 (SD38,1). Differences were statistically significant (p = 0.00667). Conclusions: Using a Chelating Cream containing lactoferrin encapsulated in liposomes, such as Kelador®, accelerates the reduction of bruise colour after a periocular intervention such as blepharoplasty.","PeriodicalId":15008,"journal":{"name":"Journal of applied cosmetology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43807297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cattaneo, Veronica Cattaneo, G.Rizzi G.Rizzi, R. V. R. Vicini, F. F. F. Ferulli, C. A. C. Angelinetta, O. P. O. Pastoris, M. B. C. M. Barbieri Carones
Urinary incontinence (UI) is a widespread condition affecting about 200 million people worldwide, with women affected more often than men and prevalence increasing with age. UI is a significant health problem that negatively impacts affected women’s well-being, sociality, and productivity. Therefore, seeking medical advice is highly recommended since valid treatment options exist. However, a definitive solution to the problem is not always possible. In these cases, absorbent containment products can help women deal with the persistent symptoms of incontinence, minimising the effects on the quality of life. High-quality products are paramount to avoid or reduce the onset of irritating skin phenomena, which can sometimes lead to more serious consequences, such as skin infections. Cotton is a natural fibre characterised by softness and hypoallergenic properties that has already shown its ability to improve skin health when used as a component of pads and other absorbent containment products. The aim of this work was to assess the safety and efficacy of a new organic cotton pull-on absorbent product in reducing skin erythema and oedema in women suffering from moderate to heavy urinary incontinence. In-vitro and clinical studies were performed. Results showed that the tested product effectively reduces skin erythema and oedema caused by the conventional use of synthetic pull-on absorbent products. Moreover, good compliance with the use was demonstrated compared to a non-cotton competitor device available on the market. In conclusion, the organic cotton absorbent device tested has improved the quality of life of women suffering from moderate to heavy urinary incontinence.
{"title":"Preclinical and clinical safety and efficacy assessment of an organic cotton medical device for the management of moderate to heavy urinary incontinence","authors":"Cattaneo, Veronica Cattaneo, G.Rizzi G.Rizzi, R. V. R. Vicini, F. F. F. Ferulli, C. A. C. Angelinetta, O. P. O. Pastoris, M. B. C. M. Barbieri Carones","doi":"10.56609/jac.v40i2.23","DOIUrl":"https://doi.org/10.56609/jac.v40i2.23","url":null,"abstract":"Urinary incontinence (UI) is a widespread condition affecting about 200 million people worldwide, with women affected more often than men and prevalence increasing with age. UI is a significant health problem that negatively impacts affected women’s well-being, sociality, and productivity. Therefore, seeking medical advice is highly recommended since valid treatment options exist. However, a definitive solution to the problem is not always possible. In these cases, absorbent containment products can help women deal with the persistent symptoms of incontinence, minimising the effects on the quality of life. High-quality products are paramount to avoid or reduce the onset of irritating skin phenomena, which can sometimes lead to more serious consequences, such as skin infections. Cotton is a natural fibre characterised by softness and hypoallergenic properties that has already shown its ability to improve skin health when used as a component of pads and other absorbent containment products. The aim of this work was to assess the safety and efficacy of a new organic cotton pull-on absorbent product in reducing skin erythema and oedema in women suffering from moderate to heavy urinary incontinence. In-vitro and clinical studies were performed. Results showed that the tested product effectively reduces skin erythema and oedema caused by the conventional use of synthetic pull-on absorbent products. Moreover, good compliance with the use was demonstrated compared to a non-cotton competitor device available on the market. In conclusion, the organic cotton absorbent device tested has improved the quality of life of women suffering from moderate to heavy urinary incontinence.","PeriodicalId":15008,"journal":{"name":"Journal of applied cosmetology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47554262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M.A. Malinowska M.A. Malinowska, A. D. A. Dziki, A. M. A. Matusik-Tabor
Consumer awareness and the desire to reach for cosmetics with natural ingredients are still growing. The active ingredients of plants can reduce acne lesions and skin redness accompanying them. Specialised cosmetic formulations should support Anti-acne products containing therapeutic agents, reducing visible skin inflammation. These products should act simultaneously, ensuring proper skincare due to the content of plant metabolites exhibiting desired biological activity. In this study, the application of a selected plant extract in cosmetic preparations for acne skincare containing selected plant extracts was prepared: Arnica montana flower, Sambucus nigra and Rosmarinus officinalis leaf, Saponaria officinalis root, Aloe barbadensis leaf juice and Silybum marianum seed oil and then their effects were compared. The extracts were applied as active ingredients in face cream, serum and micellar solution forulations. The physicochemical properties (pH value, stability, dispersed phase particle size and type of emulsion) were evaluated; moreover, rheological tests of the samples were carried out, and the skin cleansing ability of the micellar solution was examined. In addition, all the formulations were subject to various tests, which allowed for the evaluation of their organoleptic properties. It was noticed that the used plant raw materials affect the care of the skin with acne tendencies. Both extracts (Arnica montana flower extract and Sambucus nigra extract) were used in the same concentrations in the cosmetics so that differences in results were easy to compare. Importantly, during the consumer tests, the probants discontinued usage of other anti-acne agents normally applied, which allowed for an objective assessment of the effect of the tested extracts on the acne skin. The formulations tested were proven to be effective cosmetics supporting anti-acne therapy.
{"title":"The potential of selected plant extracts in anti-acne skincare formulations","authors":"M.A. Malinowska M.A. Malinowska, A. D. A. Dziki, A. M. A. Matusik-Tabor","doi":"10.56609/jac.v40i2.24","DOIUrl":"https://doi.org/10.56609/jac.v40i2.24","url":null,"abstract":"Consumer awareness and the desire to reach for cosmetics with natural ingredients are still growing. The active ingredients of plants can reduce acne lesions and skin redness accompanying them. Specialised cosmetic formulations should support Anti-acne products containing therapeutic agents, reducing visible skin inflammation. These products should act simultaneously, ensuring proper skincare due to the content of plant metabolites exhibiting desired biological activity. In this study, the application of a selected plant extract in cosmetic preparations for acne skincare containing selected plant extracts was prepared: Arnica montana flower, Sambucus nigra and Rosmarinus officinalis leaf, Saponaria officinalis root, Aloe barbadensis leaf juice and Silybum marianum seed oil and then their effects were compared. The extracts were applied as active ingredients in face cream, serum and micellar solution forulations. The physicochemical properties (pH value, stability, dispersed phase particle size and type of emulsion) were evaluated; moreover, rheological tests of the samples were carried out, and the skin cleansing ability of the micellar solution was examined. In addition, all the formulations were subject to various tests, which allowed for the evaluation of their organoleptic properties. It was noticed that the used plant raw materials affect the care of the skin with acne tendencies. Both extracts (Arnica montana flower extract and Sambucus nigra extract) were used in the same concentrations in the cosmetics so that differences in results were easy to compare. Importantly, during the consumer tests, the probants discontinued usage of other anti-acne agents normally applied, which allowed for an objective assessment of the effect of the tested extracts on the acne skin. The formulations tested were proven to be effective cosmetics supporting anti-acne therapy.","PeriodicalId":15008,"journal":{"name":"Journal of applied cosmetology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45544645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A new device for the treatment of localized adiposity","authors":"P. Amori, G. V. G. Vitiello, R. Sadoughifar","doi":"10.56609/jac.v40i2.30","DOIUrl":"https://doi.org/10.56609/jac.v40i2.30","url":null,"abstract":"<jats:p>.</jats:p>","PeriodicalId":15008,"journal":{"name":"Journal of applied cosmetology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47860522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. T. A. Tammaro, G.A.R. Adebanjo G.A.R. Adebanjo, C. C. C. Chello, A. C. A. Capalbo, S. A. S. Alexander, G. T. G. Trischitta, M. P. M. Pezza, E. C. E. Cavalieri, P. P. P. Pellegrini
{"title":"Bullous pemphigoid associated with pleural mesothelioma: a controversial etiology. Were the bullous lesions induced by pembrolizumab or related to malignancy?","authors":"A. T. A. Tammaro, G.A.R. Adebanjo G.A.R. Adebanjo, C. C. C. Chello, A. C. A. Capalbo, S. A. S. Alexander, G. T. G. Trischitta, M. P. M. Pezza, E. C. E. Cavalieri, P. P. P. Pellegrini","doi":"10.56609/jac.v40i2.29","DOIUrl":"https://doi.org/10.56609/jac.v40i2.29","url":null,"abstract":"","PeriodicalId":15008,"journal":{"name":"Journal of applied cosmetology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44675987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：